Aktuelle News
News Funktionen
Weitere Funktionen
23 Oktober 2019
Eli Lilly and Company
Correction d’un communiqué du 23.10.2019, 17:55 CET/CEST – Eli Lilly and Company: Q319LillySalesandEarningsPressRelease
Eli Lilly and Company
Eli Lilly and Company: Q319LillySalesandEarningsPressRelease
Eli Lilly and Company
Eli Lilly and Company: Lilly Reports Strong Third-Quarter 2019 Financial Results, Raises 2019 EPS Guidance
10 Oktober 2019
Eli Lilly and Company
Eli Lilly and Company: Files Form 3 and 4
3 Oktober 2019
Eli Lilly and Company
Eli Lilly and Company: Lilly Announces Voluntary Delisting from Euronext Paris
2 August 2019
Eli Lilly and Company
Eli Lilly and Company: Eli Lilly and Company Files 10-Q
30 Juli 2019
Eli Lilly and Company
Eli Lilly and Company: Eli Lilly and Company Files 8-K
Eli Lilly and Company
Eli Lilly and Company: Lilly Reports Second-Quarter 2019 Financial Results, Raises 2019 EPS Guidance
11 Juli 2019
Eli Lilly and Company
Eli Lilly and Company: Eli Lilly and Company Files Form 4
19 Juni 2019
Eli Lilly and Company
Eli Lilly and Company: Lilly Declares Third-Quarter 2019 Dividend
9 Mai 2019
Eli Lilly and Company
Eli Lilly and Company: Eli Lilly and Company Files 8-K
3 Mai 2019
Eli Lilly and Company
Eli Lilly and Company: Eli Lilly and Company Files 10-Q
30 April 2019
Eli Lilly and Company
Eli Lilly and Company: Eli Lilly and Company Files 8-K
Eli Lilly and Company
Eli Lilly and Company: Lilly Reports Solid First-Quarter 2019 Financial Results, Updates 2019 Guidance to Reflect Disposition of Elanco Animal Health
2 April 2019
Eli Lilly and Company
Eli Lilly and Company: ELI LILLY AND COMPANY FILES FORM 3, FORM 4, and FORM 5
22 März 2019
Eli Lilly and Company
Eli Lilly and Company: Eli Lilly and Company calls company stockholders meeting
25 Februar 2019
Eli Lilly and Company
Eli Lilly and Company: Eli Lilly and Company Files Preliminary Proxy
19 Februar 2019
Eli Lilly and Company
Eli Lilly and Company: Eli Lilly and Company Files 10-K
8 Februar 2019
Eli Lilly and Company
Eli Lilly and Company: Eli Lilly and Company Announces Plan for Divestiture of its Remaining Interest in Elanco Animal Health
7 Februar 2019
Eli Lilly and Company
Eli Lilly and Company: Lilly Reports Strong Fourth-Quarter and Full-Year 2018 Financial Results, Lowers 2019 EPS Guidance to Reflect the Pending Acquisition of Loxo Oncology
6 Februar 2019
Eli Lilly and Company
Eli Lilly and Company: Eli Lilly and Company files 8-K
8 Januar 2019
Eli Lilly and Company
Eli Lilly and Company: Eli Lilly and Company files 8-K
7 Januar 2019
Eli Lilly and Company
Eli Lilly and Company: Lilly Announces Agreement To Acquire Loxo Oncology
19 Dezember 2018
Eli Lilly and Company
Eli Lilly and Company: Eli Lilly and Company Files 8-K
Eli Lilly and Company
Eli Lilly and Company: Lilly Announces Financial Guidance, Reviews Commercial Performance, and Highlights Promising Pipeline Opportunities at Investment Community Meeting
Eli Lilly and Company
Eli Lilly and Company: Lilly Announces 15 Percent Dividend Increase
18 Dezember 2018
Eli Lilly and Company
Eli Lilly and Company: Eli Lilly and Company Files an 8-K
6 November 2018
Eli Lilly and Company
Eli Lilly and Company: Eli Lilly and Company Files 10-Q
Eli Lilly and Company
Eli Lilly and Company: Eli Lilly and Company Files Form 8-K
Eli Lilly and Company
Eli Lilly and Company: Lilly Delivers Solid Third-Quarter 2018 Results, Revises EPS Guidance